via The Scientist RSS https://ift.tt/33xURGA Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance SARS-CoV-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements. https://ift.tt/eA8V8J May 11, 2021 at 02:05AM